Get started
Author

Joseph Emil Amegadzie

Observed names: Amegadzie, Joseph Emil, J E Amegadzie, J. Amegadzie, J.E. Amegadzie, JOSEPH AMEGADZIE, Joseph Amegadzie, Joseph E. Amegadzie
Observed institutions: Memorial University of Newfoundland, University of British Columbia, St. Paul's Hospital, BC Centre for Disease Control, Vancouver Coastal Health Research Institute, Centre for Heart Lung Innovation
ORCID: 0000-0002-0459-7241
Observed ORCID: 0000-0002-0459-7241
OpenAlex ID: A5080634894
QRISK3 underestimates the risk of cardiovascular events in patients with COPD
2023 · Joseph Emil Amegadzie, Zhiwei Gao, et al. · Thorax · 39
PDF
Trends in hospital admissions for chronic obstructive pulmonary disease over 16 years in Canada
2023 · Joseph E. Amegadzie, Tae Yoon Lee, et al. · Canadian Medical Association Journal · 32
PDF
Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study
2022 · Joseph Emil Amegadzie, John-Michael Gamble, et al. · International Journal of COPD · 26
PDF
20-year trends in excess costs of COPD
2024 · Joseph Emil Amegadzie, Jeenat Mehareen, et al. · European Respiratory Journal · 24
Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis
2019 · Joseph Emil Amegadzie, Jessica Gorgui, et al. · Journal of Asthma · 15
Gender Differences in Inhaled Pharmacotherapy Utilization in Patients with Obstructive Airway Diseases (OADs): A Population-Based Study
2020 · Joseph Emil Amegadzie, John-Michael Gamble, et al. · International Journal of COPD · 12
PDF
Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD
2025 · Mohsen Sadatsafavi, Marc Miravitlles, et al. · Thorax · 7
PDF
The increasing burden of asthma acute care in Singapore: an update on 15-year population-level evidence
2023 · Laura Huey Mien Lim, Wenjia Chen, et al. · BMC Pulmonary Medicine · 7
PDF
Risk of all-cause mortality or hospitalization for pneumonia associated with inhaled β2-agonists in patients with asthma, COPD or asthma-COPD overlap
2022 · Joseph Emil Amegadzie, John-Michael Gamble, et al. · Respiratory Research · 6
PDF
A long overdue recognition: COPD as a distinct predictor of cardiovascular disease risk
2023 · Joseph Emil Amegadzie, Mohsen Sadatsafavi · European Respiratory Journal · 5
Performance of multivariable risk prediction algorithms in predicting COPD exacerbations: a population-based study
2026 · Jeenat Mehareen, Laura Huey Mien Lim, et al. · Thorax · 2
Validated methods to identify patients with asthma–COPD overlap in healthcare databases: a systematic review protocol
2019 · Joseph Emil Amegadzie, Oluwatosin Badejo, et al. · BMJ Open · 2
PDF
The Financial Burden of Prescribed Medications in COPD
2026 · Jeenat Mehareen, Mohsen Sadatsafavi, et al. · CHEST Pulmonary · 1
The High Burden of Asthma Acute Care in Singapore in the Next 20 Years
2023 · LAURA HUEY MIEN LIM, WENJIA CHEN, et al. · CHEST Journal · 1
PDF
B40-09 The Economic Burden of Long Covid in British Columbia, Canada
2026 · J E Amegadzie, J Li, et al. · American Journal of Respiratory and Critical Care Medicine
Performance of cardiovascular disease risk prediction tools in chronic obstructive pulmonary disease
2026 · Samaneh Salimian, Nathaniel M Hawkins, et al. · Annals of the American Thoracic Society
PDF
P291 Comparison of Cardiovascular Risk Prediction Tools in Patients With Copd: Pooled Analysis of Five Us Cohort Studies
2025 · R. Turgeon, S. Salimian, et al. · Canadian Journal of Cardiology
The Financial Burden of Prescription Medications in Chronic Obstructive Pulmonary Disease
2025 · J.E. Amegadzie, J. Mehareen, et al. · American Journal of Respiratory and Critical Care Medicine
Development and Validation of PRECISE-X, a Risk Prediction Model for the First Severe Exacerbation in Patients with Chronic Obstructive Pulmonary Disease
2025 · Mohsen Sadatsafavi, Marc Miravitlles, et al. · SSRN Electronic Journal
Twenty-year trends in excess costs of chronic obstructive pulmonary disease.
2024 · Joseph Amegadzie, Amir Khakban, et al. · Epidemiology
Twenty-year Trends in Excess Costs of Chronic Obstructive Pulmonary Disease
2024 · J. Amegadzie, J. Mehareen, et al.
Are Commonly Used Cardiovascular Risk Scoring Tools Reliable in Patients With Chronic Obstructive Pulmonary Disease (copd)?
2023 · JOSEPH AMEGADZIE, ZHIWEI GAO, et al. · CHEST Journal
PDF
Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma–COPD overlap: a systematic review and meta-analysis
2019 · Amegadzie, Joseph Emil, Gorgui, Jessica, et al. · Figshare
Works count: 25
Citation count: 178
H-index: 7
I10-index: 6
Year
Topic
Type